These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19736063)

  • 21. The year in cardiovascular surgery.
    Jones RH
    J Am Coll Cardiol; 2006 May; 47(10):2094-107. PubMed ID: 16697330
    [No Abstract]   [Full Text] [Related]  

  • 22. Percutaneous coronary intervention versus coronary-artery bypass grafting.
    Edwards JL
    N Engl J Med; 2009 Jun; 360(25):2672-3; author reply 2674-5. PubMed ID: 19537314
    [No Abstract]   [Full Text] [Related]  

  • 23. Current indications for percutaneous coronary intervention for chronic stable angina: implications of the COURAGE Trial.
    Kiernan TJ; Prasad A; Gersh BJ
    Rev Cardiovasc Med; 2007; 8(4):234-9. PubMed ID: 18192947
    [No Abstract]   [Full Text] [Related]  

  • 24. Secondary coronary revascularisation: an emerging issue.
    Escaned J
    EuroIntervention; 2009 May; 5 Suppl D():D6-D13. PubMed ID: 19736074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The distinct role of secondary prevention in patients with prior coronary interventions.
    Colmenarez H; Escaned J
    EuroIntervention; 2009 May; 5 Suppl D():D131-8. PubMed ID: 19736062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical therapy versus percutaneous coronary intervention for patients with stable coronary artery disease.
    Arbab-Zadeh A
    J Am Coll Cardiol; 2009 Feb; 53(6):528-9; author reply 529. PubMed ID: 19195616
    [No Abstract]   [Full Text] [Related]  

  • 27. [Left main coronary stenting is safe and effective and is a valuable alternative to coronary artery bypass graft surgery].
    Sheiban I; Zoccai GB; Moretti C
    G Ital Cardiol (Rome); 2009 Feb; 10(2):113-7; discussion 117. PubMed ID: 19348149
    [No Abstract]   [Full Text] [Related]  

  • 28. Almanac 2011: stable coronary artery disease. An editorial overview of selected research that has driven recent advances in clinical cardiology.
    Henderson RA; Timmis AD
    Heart; 2011 Oct; 97(19):1552-9. PubMed ID: 21900584
    [No Abstract]   [Full Text] [Related]  

  • 29. Coronary artery bypass grafting versus stenting for unprotected left main coronary artery disease: where lies the body of proof?
    Shemin RJ
    Circulation; 2008 Dec; 118(23):2326-9. PubMed ID: 19047591
    [No Abstract]   [Full Text] [Related]  

  • 30. Transmyocardial laser revascularization: from randomized trials to clinical practice. A review of techniques, evidence-based outcomes, and future directions.
    Allen KB; Kelly J; Borkon AM; Stuart RS; Daon E; Pak AF; Zorn GL; Haines M
    Anesthesiol Clin; 2008 Sep; 26(3):501-19. PubMed ID: 18765220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.
    Teo KK; Sedlis SP; Boden WE; O'Rourke RA; Maron DJ; Hartigan PM; Dada M; Gupta V; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
    J Am Coll Cardiol; 2009 Sep; 54(14):1303-8. PubMed ID: 19778673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intra-aortic balloon pump counterpulsation: the method of choice for supported "high risk" coronary angioplasty.
    Giorgi LV; Hartzler GO
    J Invasive Cardiol; 1990; 2(4):157-9. PubMed ID: 10148975
    [No Abstract]   [Full Text] [Related]  

  • 33. Re: One year perspective on COURAGE.
    Sedlis SP; Boden WE; Weintraub WS; Maron DS; O'Rourke RA; Berman DS; Mancini GB;
    Catheter Cardiovasc Interv; 2009 Feb; 73(3):428. PubMed ID: 19133682
    [No Abstract]   [Full Text] [Related]  

  • 34. Increased perioperative mortality in elective coronary artery bypass grafting after previous percutaneous coronary intervention.
    Gomes WJ
    J Thorac Cardiovasc Surg; 2009 Nov; 138(5):1253; author reply 1253. PubMed ID: 19837224
    [No Abstract]   [Full Text] [Related]  

  • 35. The link between previous percutaneous coronary intervention and coronary artery bypass graft risk.
    Bhindi R; Omerod OJ
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):790; author reply 790. PubMed ID: 19698888
    [No Abstract]   [Full Text] [Related]  

  • 36. Application of stem cell technology for coronary artery disease at the All India Institute of Medical Sciences, New Delhi, India.
    Airan B; Talwar S; Choudhary SK; Bisoi AK; Chowdhury UK; Hote MP; Mohanty S; Seth S; Patel C; Venugopal P
    Heart Surg Forum; 2007; 10(3):E231-4. PubMed ID: 17599898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of high-intensity interval training for the rehabilitation of patients with coronary artery disease.
    Warburton DE; McKenzie DC; Haykowsky MJ; Taylor A; Shoemaker P; Ignaszewski AP; Chan SY
    Am J Cardiol; 2005 May; 95(9):1080-4. PubMed ID: 15842976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment selection for coronary artery disease: The collision of a belief system with evidence.
    Smith PK
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1050-3. PubMed ID: 19379965
    [No Abstract]   [Full Text] [Related]  

  • 39. Interventional therapy of coronary artery disease in China: retrospective and perspective.
    Shen WF
    Chin Med J (Engl); 2008 Nov; 121(22):2336-41. PubMed ID: 19080343
    [No Abstract]   [Full Text] [Related]  

  • 40. Therapeutic potentials of stem cells in cardiac diseases.
    Strauer BE; Schannwell CM; Brehm M
    Minerva Cardioangiol; 2009 Apr; 57(2):249-67. PubMed ID: 19274033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.